Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia

The risk of having microvascular complication is high among Type 2 Diabetes Mellitus (T2DM) patients. However, factors associated with the glycemic control and progression of diabetic retinopathy (DR) in T2DM patients is limited. This study aims to determine association between anti-diabetic agents,...

Description complète

Détails bibliographiques
Auteurs principaux: Huri, Hasniza Zaman, Chua, Chew Huey, Mustafa, Norasyikin, Mohamad, Nor Fadhilah, Kamalden, Tengku Ain
Format: Article
Publié: Universidade de Sao Paulo 2018
Sujets:
_version_ 1825721763759128576
author Huri, Hasniza Zaman
Chua, Chew Huey
Mustafa, Norasyikin
Mohamad, Nor Fadhilah
Kamalden, Tengku Ain
author_facet Huri, Hasniza Zaman
Chua, Chew Huey
Mustafa, Norasyikin
Mohamad, Nor Fadhilah
Kamalden, Tengku Ain
author_sort Huri, Hasniza Zaman
collection UM
description The risk of having microvascular complication is high among Type 2 Diabetes Mellitus (T2DM) patients. However, factors associated with the glycemic control and progression of diabetic retinopathy (DR) in T2DM patients is limited. This study aims to determine association between anti-diabetic agents, glycemic control and progression of diabetic retinopathy in a Malaysian population. A retrospective study conducted in a tertiary teaching hospital in Malaysia, from January 2009 until March 2014. This study enrolled 104 patients aged 40-84 years, with a mean age 63.12 ± 9.18 years. patients had non-proliferative diabetic retinopathy (NPDR, 77%) and 35% had proliferative diabetic retinopathy (PDR). Diabetic macula edema (DME) was present in 20% of NPDR patients, compared with 7% in PDR. Alpha-glucosidase inhibitor (p=0.012), age (p=0.014) and number of antidiabetic agents used (p=0.015) were significantly associated with stages of diabetic retinopathy. Family history of T2DM (p=0.039) was associated with DME. Identifying factors influencing the progression of diabetic retinopathy may aid in optimizing the therapeutic effects of anti-diabetic agents in T2DM patients.
first_indexed 2024-03-06T05:55:18Z
format Article
id um.eprints-21853
institution Universiti Malaya
last_indexed 2024-03-06T05:55:18Z
publishDate 2018
publisher Universidade de Sao Paulo
record_format dspace
spelling um.eprints-218532019-08-07T04:18:22Z http://eprints.um.edu.my/21853/ Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia Huri, Hasniza Zaman Chua, Chew Huey Mustafa, Norasyikin Mohamad, Nor Fadhilah Kamalden, Tengku Ain R Medicine The risk of having microvascular complication is high among Type 2 Diabetes Mellitus (T2DM) patients. However, factors associated with the glycemic control and progression of diabetic retinopathy (DR) in T2DM patients is limited. This study aims to determine association between anti-diabetic agents, glycemic control and progression of diabetic retinopathy in a Malaysian population. A retrospective study conducted in a tertiary teaching hospital in Malaysia, from January 2009 until March 2014. This study enrolled 104 patients aged 40-84 years, with a mean age 63.12 ± 9.18 years. patients had non-proliferative diabetic retinopathy (NPDR, 77%) and 35% had proliferative diabetic retinopathy (PDR). Diabetic macula edema (DME) was present in 20% of NPDR patients, compared with 7% in PDR. Alpha-glucosidase inhibitor (p=0.012), age (p=0.014) and number of antidiabetic agents used (p=0.015) were significantly associated with stages of diabetic retinopathy. Family history of T2DM (p=0.039) was associated with DME. Identifying factors influencing the progression of diabetic retinopathy may aid in optimizing the therapeutic effects of anti-diabetic agents in T2DM patients. Universidade de Sao Paulo 2018 Article PeerReviewed Huri, Hasniza Zaman and Chua, Chew Huey and Mustafa, Norasyikin and Mohamad, Nor Fadhilah and Kamalden, Tengku Ain (2018) Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia. Brazilian Journal of Pharmaceutical Sciences, 54 (2). e17484. ISSN 2175-9790, DOI https://doi.org/10.1590/s2175-97902018000217484 <https://doi.org/10.1590/s2175-97902018000217484>. https://doi.org/10.1590/s2175-97902018000217484 doi:10.1590/s2175-97902018000217484
spellingShingle R Medicine
Huri, Hasniza Zaman
Chua, Chew Huey
Mustafa, Norasyikin
Mohamad, Nor Fadhilah
Kamalden, Tengku Ain
Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
title Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
title_full Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
title_fullStr Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
title_full_unstemmed Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
title_short Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
title_sort association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in malaysia
topic R Medicine
work_keys_str_mv AT hurihasnizazaman associationofglycemiccontrolwithprogressionofdiabeticretinopathyintype2diabetesmellituspatientsinmalaysia
AT chuachewhuey associationofglycemiccontrolwithprogressionofdiabeticretinopathyintype2diabetesmellituspatientsinmalaysia
AT mustafanorasyikin associationofglycemiccontrolwithprogressionofdiabeticretinopathyintype2diabetesmellituspatientsinmalaysia
AT mohamadnorfadhilah associationofglycemiccontrolwithprogressionofdiabeticretinopathyintype2diabetesmellituspatientsinmalaysia
AT kamaldentengkuain associationofglycemiccontrolwithprogressionofdiabeticretinopathyintype2diabetesmellituspatientsinmalaysia